Black Rock Inc. Lensar, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Lensar, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 153,517 shares of LNSR stock, worth $1.34 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

153,517

Previous 148,471 3.4%

Holding current value

$1.34 Million

Previous $504,000 36.9%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$3.0 - $4.88 $15,138 - $24,624	5,046 Added 3.4%	153,517 $690,000
Q1 2024 May 10, 2024	SELL	$3.25 - $5.0 $27,560 - $42,400	-8,480 Reduced 5.4%	148,471 $504,000
Q4 2023 Feb 13, 2024	SELL	$2.01 - $3.51 $393 - $687	-196 Reduced 0.12%	156,951 $550,000
Q3 2023 Nov 13, 2023	SELL	$3.02 - $4.45 $21,478 - $31,648	-7,112 Reduced 4.33%	157,147 $485,000
Q2 2023 Aug 11, 2023	BUY	$2.3 - $4.34 $5,204 - $9,821	2,263 Added 1.4%	164,259 $698,000
Q1 2023 May 12, 2023	SELL	$2.19 - $3.27 $24,694 - $36,872	-11,276 Reduced 6.51%	161,996 $403,000
Q4 2022 Feb 13, 2023	BUY	$2.7 - $5.9 $75 - $165	28 Added 0.02%	173,272 $512,000
Q3 2022 Nov 14, 2022	SELL	$4.94 - $7.0 $4,258 - $6,034	-862 Reduced 0.5%	173,244 $962,000
Q2 2022 Aug 12, 2022	SELL	$6.15 - $7.94 $10,910 - $14,085	-1,774 Reduced 1.01%	174,106 $1.13 Million
Q1 2022 May 12, 2022	SELL	$5.8 - $8.2 $8,381 - $11,848	-1,445 Reduced 0.81%	175,880 $1.3 Million
Q4 2021 Feb 10, 2022	SELL	$5.9 - $7.84 $14,101 - $18,737	-2,390 Reduced 1.33%	177,325 $1.06 Million
Q3 2021 Nov 09, 2021	SELL	$7.5 - $8.88 $22,995 - $27,226	-3,066 Reduced 1.68%	179,715 $1.38 Million
Q2 2021 Aug 11, 2021	BUY	$6.87 - $8.66 $1.26 Million - $1.58 Million	182,781 New	182,781 $1.58 Million

Others Institutions Holding LNSR

# of Institutions

Shares Held

4.91M

Call Options Held

700

Put Options Held

31.3K

View Full List

About LENSAR, Inc.

Ticker LNSR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 11,021,000
Market Cap $96.4M
Description
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in...

More about LNSR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account